• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Testosterone replacement may improve anemia in older men with low testosterone

byAnees DaudandShayna Bejaimal
February 22, 2017
in Chronic Disease, Endocrinology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In this non-randomized, double-blind, placebo-controlled study, men 65 years or older who had unexplained anemia with low serum testosterone had an increase in their measured serum hemoglobin with testosterone replacement.

2. Hemoglobin levels increased with testosterone therapy in patients with explained and unexplained anemia, as well as in non-anemic men.

Evidence Rating Level: 2 (Good)       

Study Rundown: Decrease in serum testosterone commonly occurs in elderly men. Testosterone supplementation has not been demonstrated to have clear benefit but may increase risk of prostate cancer. Anemia is another common condition of older men and is often unexplained. Low serum testosterone has been associated with lower hemoglobin levels and small studies have demonstrated improvement with testosterone replacement. This double-blind, placebo-controlled study was conducted to evaluate the effect of testosterone replacement in older men with either explained or unexplained anemia.

The results of the study showed that, compared with placebo, replacement of testosterone was associated with an increase in serum hemoglobin. Hemoglobin rise was observed in treatment arms for both unexplained anemia and anemia of known cause. Hemoglobin increased amongst men without anemia as well. Testosterone supplementation was associated with a small but significant improvement in 6-minute walking distance, and subjective global impression of health. The strengths of the study included the double-blind, placebo control design, >90% follow up, and biochemical confirmation of compliance. The study opted for a minimization strategy for allocation rather than true randomization which may introduce bias. Additionally, the study sample was small and had limited ethnic diversity. Men with more profound anemia at baseline (<10 g/dL) were also not included in the study.

Click to read the study, published today in JAMA Internal Medicine

Relevant Reading: Could Testosterone Replacement Therapy in Hypogonadal Men Ameliorate Anemia, a Cardiovascular Risk Factor? An Observational, 54-Week Cumulative Registry Study

RELATED REPORTS

Ferric derisomaltose may reduce heart failure-related hospitalizations

Maternal anemia in pregnancy may be associated with subsequent brain structure changes in offspring

Summary Elixhauser score interally validated for mortality prediction in older adults

In-Depth [double-blind, placebo-controlled]: The Anemia Trial was one of 7 coordinated Testosterone Trials which enrolled men from 12 sites to participate. Men were included if they were 65 years and older, had two serum testosterone tests averaging less than 275 ng/dL, and had a hemoglobin level less than 12.7 g/dL. Participants were excluded if they had a hemoglobin less than 10.0 g/dL. Patients were evaluated to have either unexplained anemia or anemia of known cause if they had any of the following: renal insufficiency, B12/folate/iron deficiency, myelodysplasia, hemolysis, chronic inflammation, or plasma cell dyscrasia. Patients were allocated by minimization to either placebo or testosterone gel titrated to normal serum testosterone range (defined as the range in normal, young males).

Of the 788 men recruited from 2010 to 2013, 126 were anemic at baseline with 64 (50.8%) having anemia of known cause. Testosterone treatment was associated with greater likelihood of hemoglobin improvement of at least 1.0 g/dL compared to placebo among patients with unexplained anemia (aOR, 31.5; 95% CI, 3.7-277.8, p = 0.002), anemia of known cause (AOR, 8.2; 95% CI, 2.1-31.9; p = 0.003), and non-anemic men (OR, 20.7; 95% CI, 12.9-33.3; p < 0.001). In the non-anemic group, testosterone therapy was associated with erythrocytosis in 2% of participants. Improvement in hemoglobin was also associated with improvement in 6-minute walk distance by 8.3m, and global perceived health status.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: anemiatestosterone
Previous Post

Testosterone administration may increase bone mineral density in older men with low testosterone

Next Post

Transient elastography may be effective in evaluating endovascular treatment of Budd-Chiari syndrome

RelatedReports

No association found between length of storage for transfused red blood cells and patient mortality
Cardiology

Ferric derisomaltose may reduce heart failure-related hospitalizations

December 27, 2022
2 Minute Medicine Rewind July 29, 2019
Chronic Disease

Maternal anemia in pregnancy may be associated with subsequent brain structure changes in offspring

December 5, 2022
American College of Physicians releases principles to guide patient partnership in health care
Chronic Disease

Summary Elixhauser score interally validated for mortality prediction in older adults

September 19, 2022
Prophylactic platelet transfusions prevent bleeding in hematologic cancers
Chronic Disease

Mitapivat may improve anemia in adults with non-transfusion dependent α- and β-thalassemia

August 23, 2022
Next Post
Spleen elastography may be effective in the diagnosis of portal hypertension

Transient elastography may be effective in evaluating endovascular treatment of Budd-Chiari syndrome

Pre-operative magnetic resonance imaging may not improve contralateral breast cancer detection

No cardiac events in patients with pacemakers or ICDs who underwent MRI: The MagnaSafe registry

Non-TNF-targeted therapies more effective than anti-TNF agents in uncontrolled rheumatoid arthritis

2 Minute Medicine Rewind February 20, 2017

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
  • Homicide deaths are on the rise for children living in the United States
  • High-protein supplementation improves linear growth in infants
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options